amniotic fluid peptide-1, human: Clinical Trials

3 trials of amniotic fluid peptide-1, human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2
Early Phase 11Completed 1

Follow amniotic fluid peptide-1, human: new trials by email Literature Review of amniotic fluid peptide-1, human trials Research Report on amniotic fluid peptide-1, human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Zofin to Treat COVID-19 Long Haulers
Zofin, Placebo - COVID-19
Phase 1 / Phase 2CompletedZEO ScientifiX, Inc.182022-04-142023-11-01
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients
Human Amniotic Fluid - SARS CoV-2
Phase 1 / Phase 2CompletedUniversity of Utah472020-10-282023-12-21
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
Human Amniotic Fluid - SARS CoV-2 Infection
Early Phase 1CompletedUniversity of Utah102020-03-202023-04-24

Conditions studied

COVID-19 (3)  ·  Critical Illness (1)  ·  Respiratory Insufficiency (1)

Sponsors

University of Utah (2)  ·  ZEO ScientifiX, Inc. (1)

Countries

United States (3)

Top investigators

Craig Selzman, MD (2)  ·  Natasha Phrsai (1)

Results publications

PMID 33482902, PMID 33574155, PMID 38066442